Home » Find Clinical Trials
189 Results
Protocol Code
Study Title
Active substance/Medical device
Study Phase
Therapeutic Area
CL3-95005-007
An open-label, randomised, phase III study comparing trifluridine/tipiracil in combination with bevacizumab to trifluridine/tipiracil monotherapy…
TIPIRACIL, TRIFLURIDINE, S095005
Phase 3
Cancers
CL1-64315-004
Phase I/II, international, multicentre, open-label, non-randomised, non-comparative, study evaluating the safety, tolerability and clinical activity…
S064315
Phase 1-2
Cancers
CL2-95011-001
A phase IIa efficacy and safety trial with intravenous S95011 in primary Sjögren’s Syndrome patients.…
S095011
Phase 2
Immune-Inflammatory Diseases
CL3-05167-005
Efficacy and safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in adult patients with arterial…
ATORVASTATIN, PERINDOPRIL, S005167
Phase 3
Cardiovascular Diseases
CL1-95014-001
A Phase 2 Clinical Study of Pegaspargase in Patients With Newly Diagnosed, Untreated Acute Lymphoblastic…
PEGASPARGASE, S095014
Phase 2
Cancers
CL1-64315-003
A Phase I/II, open label, non-randomized study to evaluate safety, tolerability, pharmacokinetics and clinical activity…
S064315
Phase 1-2
Cancers
CL3-13001-002
Clinical Investigation to Determine the Accuracy and Benefit of Cardioskin™ in Patients With Known Atrial…
Cardioskin™
Phase 3
Cardiovascular Diseases
331602
Post Marketing Surveillance Study for ONIVYDE® in South Korea
Liposomal Irinotecan, S095013
Phase 4
Cancers
331501
Phase II Randomized Study of BAX2398 in Combination With 5-Fluorouracil and Calcium Levofolinate in Japanese…
Liposomal Irinotecan, S095013
Phase 2
Cancers
CL1-65487-002
Study of a New Intravenous Drug, Called S065487, in Patients With Acute Myeloid Leukemia, Non…
S065487
Phase 1
Cancers
CL1-64315-002
An International Phase Ib Multicentre Study to Characterize the Safety and Tolerability of Intravenously Administered…
S064315
Phase 1
Cancers
CL3-95008-002
Efficacy and safety of bumetanide oral liquid formulation in children aged from 2 to less…
BUMETANIDE, S095008
Phase 3
Neuropsychiatric Diseases
CL3-95008-001
Efficacy and safety of bumetanide oral liquid formulation in children and adolescents aged from 7…
BUMETANIDE, S095008
Phase 3
Neuropsychiatric Diseases
CL2-201086-002
Efficacy and safety of 3 doses of S201086/GLPG1972 administered orally once daily in patients with…
S201086
Phase 2
Rheumatology
Control-2
Efficacy of ivabradine in combination with beta-blockers vs up-titration of beta-blockers in daily practice
IVABRADINE, S016257
Phase 4
Cardiovascular Diseases
CL3-05153-008
A clinical study to test the safety and the efficacy of a single-pill combination of…
AMLODIPINE, ATORVASTATIN, PERINDOPRIL ARGININE, S005153
Phase 3
Cardiovascular Diseases
CL3-05682-109
Clinical non-inferiority study between Micronized purified flavonoid fraction 1000 mg, one chewable tablet per day…
MICRONISED PURIFIED FLAVONOID FRACTION, S005682
Phase 3
Cardiovascular Diseases
CL1-95010-001
Safety, Tolerability and Pharmacokinetics of S 95010 After Single Escalating Intravenous Doses in Young Healthy…
S095010
Phase 1
Cardiovascular Diseases
CL3-95005-006
An open-label, randomised, phase III Study cOmparing trifLuridine/tipiracil (S 95005) in combination with bevacizumab to…
TIPIRACIL, TRIFLURIDINE, S095005
Phase 3
Cancers
CL1-81694-003
Phase I/II trial of S 81694 administered intravenously in combination with paclitaxel to evaluate the…
S081694
Phase 1-2
Cancers
CL1-49076-002
Phase I/II study of S49076, a multi-target inhibitor of c-MET, AXL, FGFR in combination with…
S049076
Phase 1-2
Cancers
CL1-80881-002
INES - Phase Ib dose allocation study of oral administration of lucitanib given in combination…
LUCITANIB, S080881
Phase 1
Cancers
CL1-68587-001
A phase 1, open label, non-comparative, monocenter study to evaluate the safety and the ability…
UCART19, S068587
Phase 1
Cancers
IC4-95005-183-DEU
Prospective, Multicenter, Open-label Phase IV trial of Trifluridine/Tipiracil to Evaluate the Health-related Quality of Life…
TIPIRACIL, TRIFLURIDINE, S095005
Phase 4
Cancers
SC3-90049-001
Assessment of the acceptability of a sublingual formulation of piribedil (S90049), 10 to 30 mg…
PIRIBEDIL, S090049
Phase 3
Neuropsychiatric Diseases
Servier clinical trials are mainly registered on
EU Clinical Trials Register
The EU Clinical Trials Register contains information on interventional clinical trials on medicines conducted in Europe, which started after 1 May 2004.
SEE MORE
ClinicalTrials.gov
Clinicaltrials.gov is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.
SEE MORE
ISRCTN registry
The ISRCTN registry is a primary clinical trial registry recognised by WHO and ICMJE that accepts all clinical research studies.
SEE MORE
© 2021 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.